Skip to main content
NIH funding notice PAR-19-198

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Closed on November 8, 2021.

Posted
February 27, 2019
Close date
November 8, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,819,074 in first-year total cost, median $561,400.

Most frequent study sections

  1. Cancer Prevention Study Section[CPSS]4
  2. Special Emphasis Panel[ZRG1 OTC-D (08)]2
  3. Special Emphasis Panel[ZRG1 OTC-M (08)]1

Most frequent institutions

  1. CHILDREN'S HOSP OF PHILADELPHIA1
  2. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  3. MAYO CLINIC ARIZONA1
  4. UNIVERSITY OF TENNESSEE HEALTH SCI CTR1
  5. UNIVERSITY OF TX MD ANDERSON CAN CTR1
Competing awards under PAR-19-198 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA1R01CA259635-01A1WALLACE, DOUGLAS CCHILDREN'S HOSP OF PHILADELPHIA, PA$654,111ZRG1
2022Innate lymphoid cell regulation of the host-microbiota interactions in cancer1R01CA274534-01SONNENBERG, GREGORY FWEILL MEDICAL COLL OF CORNELL UNIV, NY$580,093ZRG1
2021Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen1R01CA264048-01GOUNARI, FOTINIKHAZAIE, KHASHAYARSHASTALEY, CHRISTOPHERMAYO CLINIC ARIZONA, AZ$647,791CPSS
2021Treating colon cancer by regulating intestinal immunity through microbial metabolism1R01CA259634-01ARPAIA, NICHOLASCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$561,400CPSS
2021Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer1R01CA248731-01A1KADARA, HUMAMMOGHADDAM, SEYED JAVAD MIRHASSANIUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$556,410CPSS
2021TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity1R01CA253285-01A1RUTKOWSKI, MELANIE RUNIVERSITY OF VIRGINIA, VA$401,968ZRG1
2020Role of microbial-modulated bile acid receptor signaling in breast cancer1R01CA253329-01MAKOWSKI-HAYES, LIZAPIERRE, JOSEPH FUNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN$417,301CPSS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-198: Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience